Walusimbi, Bridgious
Natukunda, Agnes
Amongin, Rebecca
Heyraud, Victoria
Baine, Claire
Nassuuna, Jacent
Webb, Emily L.
Elliott, Alison M.
Nkurunungi, Gyaviira
Funding for this research was provided by:
Royal Society (R120442)
Medical Research Council (MR/R02118X/1 ; MC_PC_21034)
National Institute for Health and Care Research (NIHR134531)
Wellcome Trust (224263/Z/21/Z)
Article History
Received: 9 February 2026
Accepted: 5 May 2026
First Online: 16 May 2026
Competing interests
: G.N. and A.M.E. report grants from Wellcome Trust. G.N. reports funding from the EDCTP2 programme supported by the European Union. A.M.E. reports funding from Medical Research Council (MRC) of the United Kingdom for conduct of the parent study; A.M.E. reports funding from NIH, Science for Africa Foundation and DELTAS Africa, outside the submitted work. B.W. and A.M.E. report funding from the Royal Society outside the submitted work. A.M.E., B.W. and A.N. report support from UK National Institute of Health and care Research (NIHR). A.M.E. further reports support from the Serum Institute of India, Uganda National Expanded Programme on Immunisation, and Emergent BioSolutions for conduct of the parent study. The other authors do not have a competing interest.